Synfacts, Inhaltsverzeichnis Synfacts 2024; 20(07): 0751DOI: 10.1055/s-0043-1774881 Innovative Drug Discovery and Development Using Artificial Intelligence to Identify TRAF2- and NCK-Interacting Kinase as a Target for FibrosisRezensent(en): Antonia F. Stepan (Roche) , Nicholas A. Meanwell (Baruch S. Blumberg Institute, U. Michigan, Rutgers. U.)Artikel empfehlen Abstract Key words Key wordsartificial intelligence - TRAF2- and NCK-interacting kinase inhibitor - anti-fibrotic activity Volltext